Nisin

Identity and spectrum

Nisin is a lantibiotic bacteriocin produced by strains of Lactococcus lactis and identified as E 234 in European additive law. It disrupts susceptible bacterial membranes through interactions that include lipid II. Activity is strongest against many Gram-positive vegetative cells; spores may be affected during germination, while Gram-negative bacteria, yeasts and moulds are generally outside its primary spectrum unless another treatment changes access. Susceptibility varies by species and strain. Nisin is therefore not a general-purpose kill agent and must not be credited against Salmonella, STEC, yeasts or surface moulds from its name alone. Commercial preparations have defined potency and carriers, so grams of preparation and units of active nisin are not interchangeable. The actual specification must be used in formulation and evidence.

Legal status and intended use. A positive safety evaluation does not authorise nisin in every meat product. The producer must check the governing additive list, food category, maximum level, specification, labelling and export market. Codex, European and national categories may differ, and a use allowed in cheese or a heat-treated product cannot be transferred automatically to fermented sausage, pâté or dry-cured meat. Nisin produced in situ by a protective culture also raises a different regulatory and process question from direct addition of a purified commercial preparation. Protected-product specifications may restrict either route. Documentation should identify the nisin preparation, potency, carrier, allergen implications where relevant, supplier status and exact legal basis. A research paper showing efficacy does not create permission for commercial use.

Matrix and process performance

Nisin performance changes with pH, temperature, salt, fat, protein binding, enzymes, target population, distribution and contact time. Activity can decline when the peptide binds to meat components or is unevenly dispersed. Fermentation acidity may improve some activity while the product matrix still limits contact. A surface application, casing treatment and internal addition create different exposure patterns. The sucuk literature shows that nisin can influence Listeria under a defined formulation and process, but the result cannot be converted into a universal log reduction. Challenge evidence should match the target organism, strain set, inoculation site, product, dose, process and storage. A measured pH or declared nisin concentration does not establish lethality. Performance belongs within the complete hurdle system and should include a realistic operating margin.

Integration with hygiene and other hurdles

Nisin may support control of susceptible Gram-positive organisms, including Listeria in some products, but it cannot compensate for post-lethality contamination, poor raw/RTE separation or an unclean slicer. High initial load can overwhelm an inhibitory treatment, and tolerant survivors may remain. Combining nisin with acidity, heat, salt, water-activity reduction or another lawful intervention can improve performance, yet interactions must be validated rather than assumed additive. It does not control mould, so a clean fungal surface says nothing about nisin function. Routine control includes correct preparation, potency conversion, uniform addition, culture compatibility and process monitoring. Verification may include formulation records, potency certificates and organism-specific challenge or shelf-life work. Finished-product testing alone has limited ability to prove uniform application or continuing control.

Deviation and disposition

Wrong preparation, potency conversion, dose, addition point or product category requires containment. Re-adding nisin after mixing or after growth has occurred may not recreate the validated exposure and does not remove toxins or metabolites. A negative Listeria sample cannot prove the whole lot received the correct treatment, while a positive result requires action under the applicable food-safety programme regardless of nominal nisin addition. Product assessment considers actual active units, distribution, target organism, other hurdles, time, temperature, post-process exposure and law. Root cause may involve supplier potency, formula units, solution stability, mixing, protein binding, resistant flora or sanitation. Release, further processing or destruction must be supported independently from the equipment or documentation correction.